SCHEMBL23844276

SCHEMBL23844276

Cc1c(NC(=O)OC(C)(C)C)ccc(Cl)c1C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40
PDK4 Q16654 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LCK P06239 3/20 0.39
KDR P35968 1/20 0.39
JAK3 P52333 1/20 0.39
MAPK14 Q16539 1/20 0.39
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
P2RX7 Q99572 1/20 0.38
ATR Q13535 1/20 0.38
ELANE P08246 1/20 0.37
CTRB1 P17538 1/20 0.37
CYP17A1 P05093 1/20 0.37
NOTUM Q6P988 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28618867 0.82 RXFP1 (0.43) LMNAPOLBRXFP1ATRELANE
SCHEMBL1291381 0.81 PDK1 (0.46) LMNAPOLBPDK1PDK2PDK3
SCHEMBL29624959 0.81 PDK1 (0.46) LMNAPOLBPDK1PDK2PDK3
SCHEMBL23844277 0.80 AR (0.48) LMNAPOLBRXFP1PDK1PDK2
SCHEMBL476879 0.77 ALDH1A1 (0.66) LMNAPOLBALDH1A1LCKP2RX7
SCHEMBL34472852 0.77 ATR (0.41) RXFP1ALDH1A1LCKHSP90AA1HSP90AB1
SCHEMBL28283537 0.76 RXFP1 (0.42) LMNAPOLBRXFP1PDK1PDK2
SCHEMBL34473354 0.75 ATR (0.40) ALDH1A1LCKP2RX7ATRELANE
SCHEMBL22507866 0.75 CYP17A1 (0.39) LMNAPOLBRXFP1PDK1PDK2
SCHEMBL6056066 0.75 RAB9A (0.54) LMNAPOLBPDK1PDK2PDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208985-A2 ANDROGEN RECEPTOR REGULATION BY SMALL MOLECULE ENANTIOMERS UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2024-06-27 US disclosed
US-20240208985-A2 ANDROGEN RECEPTOR REGULATION BY SMALL MOLECULE ENANTIOMERS UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2024-06-27 US disclosed
US-20230133119-A1 ANDROGEN RECEPTOR REGULATION BY SMALL MOLECULE ENANTIOMERS UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2023-05-04 US disclosed
WO-2021189051-A1 ANDROGEN RECEPTOR REGULATION BY SMALL MOLECULE ENANTIOMERS UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2021-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208985-A2 ANDROGEN RECEPTOR REGULATION BY SMALL MOLECULE ENANTIOMERS AR, SHBG, NR5A1 LMNA 3917/4885POLB 2782/4885RXFP1 626/4885
US-20230133119-A1 ANDROGEN RECEPTOR REGULATION BY SMALL MOLECULE ENANTIOMERS AR, SHBG, NR5A1 LMNA 3918/4885POLB 2737/4885RXFP1 650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.